Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models. [electronic resource]
Producer: 20191230Description: 2888-2906 p. digitalISSN:- 1550-6606
- Agammaglobulinaemia Tyrosine Kinase -- antagonists & inhibitors
- Animals
- Arthritis, Rheumatoid -- drug therapy
- B-Lymphocytes -- enzymology
- Disease Models, Animal
- Female
- Humans
- Lupus Erythematosus, Systemic -- drug therapy
- Lymphocyte Activation -- drug effects
- Mice
- Piperidines -- pharmacology
- Pyrimidines -- pharmacology
- U937 Cells
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.